What is the market valuation of biopreservation?

The market revenue for biopreservation is anticipated at USD 7.48 billion in 2027.

What are the growth projections for the biopreservation industry?

Biopreservation Market size was valued at USD 6.1 billion in 2026 and is projected to grow at a 26.89% CAGR from 2027 to 2036, crossing USD 66.01 billion by 2036.

How is expanding cell and gene therapy activity influencing demand in the biopreservation market?

Expanding hospital and laboratory use alongside cell and gene therapy workflows is increasing reliance on controlled storage, transport, and handling systems. This raises demand for reliable preservation solutions that maintain viability and prevent sample loss across clinical and research processes.

What role is AI and automation playing in improving biopreservation practices?

AI-driven monitoring and automated cryopreservation systems are improving temperature control, freezing precision, and process consistency. This supports better sample integrity and reduces manual variability, encouraging adoption of integrated preservation systems combining sensors, software, and controlled-rate freezing technologies.

Why is equipment the largest product segment in the biopreservation market?

Equipment led the biopreservation market with a 75.6% share in 2026 because reliable storage and temperature-control systems are essential for preserving biological materials across laboratories, repositories, and clinical environments.

Why is regenerative medicine the fastest-growing application in the biopreservation market?

Regenerative medicine is expanding fastest because preserving the viability and functional integrity of sensitive cells and tissues has become increasingly important as advanced biologic and precision treatment workflows continue to grow.

Why is North America the leading region in the biopreservation market?

North America held a 47.70% market share in 2026, supported by advanced biobanking infrastructure, widespread clinical research, established cold-chain systems, and strong demand from pharmaceutical and healthcare laboratories.

What factors are accelerating biopreservation market growth in Asia Pacific?

Asia Pacific is projected to grow at a 30.14% CAGR, fueled by expanding life sciences research, rising regenerative medicine investments, growing biobanking activity, and broader adoption of advanced preservation workflows.

Which companies dominate the biopreservation landscape?

Prominent players in the biopreservation market include Thermo Fisher Scientific Inc. (United States), Azenta, Inc. (United States), BioLife Solutions, Inc. (United States), Panasonic Holdings Corporation (Japan), MVE Biological Solutions (United States), Stirling Ultracold (United States), X-Therma Inc. (United States), LabVantage Solutions, Inc. (United States).